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Abbreviations: CIA, chronic immune activation; IFN-I, interferon type I; L, ligand; 
DCs, dendritic cells; ACTB, actin cytoplasmic 1; ROK, heterogeneous nuclear 
ribonucleoprotein; LAM1, lamin B1; MYH9, non-muscle myosin heavy chain 9; 
VIME, vimentin; PSA1, proteasome component C2; GDIS, rho GDP dissociation 
inhibitor 2; RLA, 60S acidic ribosomal protein P2; AEs, apoptotic epitopes; MHC, 
major histocompatibility complex; HCV, hepatitis C virus; MS, multiple sclerosis; c, 
chronic; DAAs, direct-acting antiviral agents; PD, programmed death; TIM-3, T cell 
immunoglobulin mucin-3; IFN, interferon; ISGs, interferon-stimulated genes; TNF, 
tumor necrosis factor; PBMCs, peripheral blood mononuclear cells; LILs, liver-
infiltrating lymphocytes; ELISPOT, enzyme-linked immunospot; IL, interleukin; RT-
PCR, reverse transcription polymerase chain reaction; NK, natural killer; mAb, 
monoclonal antibody; HDs, healthy donors; ALT, alanine aminotransferase; HAI, 
histological activity index; t, transcripts; PKR, protein kinase R; ds, double-stranded; 
MxA, myxovirus resistance A; pIFN/RIBA, pegylated IFN--ribavirin; TEM, effector 
memory; TEMRA, terminal effector memory RA; Eomes, Eomesodermin; T-bet, T-
box transcription factor; TN, naïve T; TCM, central memory T; USP, ubiquitin 
specific protease 18; CTLA-4, cytotoxic T-lymphocyte-associated protein 4; HBV, 
hepatitis B virus. 
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Abstract 
CD8+ T cells specific to caspase-cleaved antigens derived from apoptotic T cells 
represent a principal player in chronic immune activation (CIA). Here, we found that 
both apoptotic epitope (AE)-specific and hepatitis C virus (HCV)-specific CD8+ T 
cells were mostly confined within the effector memory (EM) or terminally 
differentiated EM CD45RA+ cell subsets expressing a dysfunctional T-helper-1-like 
signature program in chronic (c)HCV infection. However, AE-specific CD8+ T cells 
produced tumor necrosis factor (TNF)- and interleukin-2 at the intrahepatic level 
significantly more than HCV-specific CD8+ T cells, despite both populations 
acquiring high levels of programmed death-1 receptor expression. Contextually, 
only AE-specific CD8+ T cells correlated with both interfero -stimulated gene levels 
in T cells and hepatic fibrosis score. Taken together, these data suggest that AE-
specific CD8+ T cells can sustain CIA by their capacity to produce TNF-and be 
resistant to inhibitory signals more than HCV-specific CD8+ T cells in cHCV 
infection.  
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Introduction 
The phenomenon of chronic immune activation (CIA) [1-3] is a hallmark of several 
chronic immune-mediated diseases and is attributed to polyclonal hyperactivation of 
B and T cells caused by both antigen-dependent (e.g. self-antigens) and antigen-
independent (e.g. bystander activation) stimuli [1, 4]. Generally, CIA occurs 
subsequent to a primary immune response specific to persistent infections and, 
ultimately, amplifies chronic immunopathology [5, 6]. In HIV infection, CIA is closely 
linked to CD4+ T cell apoptosis and depletion, sustains viral replication, and 
associates with progression toward AIDS [1, 2, 4]. Recent experimental evidence 
has demonstrated that a direct causal link exists between disease progression in 
persistent viral infections and chronic interferon type I (IFN-I) signaling, CIA, and 
increased expression of negative immune regulatory molecules and that blockade 
of IFN-I signaling diminishes CIA and immune suppression, ultimately redirecting 
the immune environment to enable control of infection [7, 8].  
We previously proposed that the enormous number of apoptotic cells resulting from 
the rapid turnover of effector T cells during inflammatory diseases contributes to 
establishing CIA, on the basis of the following three pieces of evidence [2, 5, 9, 10]. 
First, apoptotic cells derived from activated T cells retain the expression of CD40 
ligand (L) and, in contrast to CD40L– apoptotic cells (e.g. those derived from 
epithelial cells), can condition CD40+ dendritic cells (DCs) to acquire high 
stimulatory capacities [11-13]. Second, apoptotic T cells that have been 
phagocytosed by DCs can release, within phagosomes, caspase-cleaved 
fragments, particularly from actin cytoplasmic 1 (ACTB), heterogeneous nuclear 
ribonucleoprotein (ROK), lamin B1 (LAM1), non-muscle myosin heavy chain 9 
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(MYH9), vimentin (VIME), proteasome component C2 (PSA1), rho GDP dissociation 
inhibitor 2 (GDIS), and 60S acidic ribosomal protein P2 (RLA).  Third these 
fragments are efficiently translocated into cytosol, processed, and, ultimately, cross-
presented as distinct epitopes (apoptotic epitopes [AEs]) on major histocompatibility 
complex (MHC) class I molecules to a wide repertoire of autoreactive AE-specific 
CD8+ T cells [2, 5]. In chronic (c) HIV or acute hepatitis C virus (HCV) infections, the 
proportion of AE-specific CD8+ T cells correlates with the proportion of circulating 
apoptotic CD4+ T cells in vivo and with the disease progression, supporting the 
opinion that apoptotic T cells increase in relation to the level of T cell activation 
during the disease evolution and represent a preponderant source of the apoptotic 
antigens [2, 3]. The emergence and the maintenance of these responses contribute 
to intensify the CIA [1-3], not only in viral infections but also in autoimmune 
diseases such as multiple sclerosis (MS) [14] or rheumatoid arthritis [15], through 
their capacity to produce high levels of inflammatory cytokines in response to AEs. 
Therefore, CIA induced by CD8+ T cell autoimmunity to AEs seems to be a general 
mechanism in both viral and autoimmune diseases. 
To examine in-depth the multifaceted aspects of the amplification and spreading of 
CIA, we studied the dynamics of both AE-specific and virus-specific CD8+ T cell 
responses in cHCV infection. Despite the recent availability of highly effective direct-
acting antiviral agents (DAAs) providing complete viral clearance [16], HCV infection 
remains, to date, a unique example of a natural, extremely widespread infection that 
can be exploited to understand the intersecting mechanisms of chronic 
immunopathology. Studies on the natural history of HCV infection indicate that 
chronic evolution correlates with the acquisition of HCV-specific T cell dysfunction 
[17-23], which has been particularly associated with the expression of programmed 
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death (PD)-1 receptor and/or T cell immunoglobulin mucin-3 (TIM-3), inducing T cell 
exhaustion upon contact with the corresponding ligands [23-28].  
Our data show that the frequency of AE-specific (but not HCV-specific) CD8+ T cells 
correlates with the evolution of cHCV infection and the level of various IFN-
stimulated genes (ISGs), suggesting that ISGs can regulate AE-specific CD8+ T 
cells in establishing CIA and that AE-specific CD8+ T cells may ultimately amplify 
liver immunopathology, particularly by the production of tumor necrosis factor 
(TNF)-.  
 
Patients and methods 
Please refer to the Supplementary Materials for more detailed descriptions. 
Patients 
Twenty HLA-A2+ patients (11 males and 9 females) with cHCV infection were 
enrolled in this study for diagnostic evaluation and follow-up assessment. The 
clinical characteristics of the patients included are shown in Supplementary Table 
1. 
Samples and processing 
The isolation of peripheral blood mononuclear cells (PBMCs) and liver-infiltrating 
lymphocytes (LILs) and the detection of T cell apoptosis are detailed in 
Supplementary Materials. 
Synthetic peptides 
The descriptions of procedures and lists of synthetic peptides (Supplementary 
Tables 2 and 3) are reported in Supplementary Materials. 
Ex vivo and in vitro assays 
The methods for assays of enzyme-linked immunospot (ELISPOT), PD-1-
dependent inhibitory function, RNA purification, and real-time reverse transcription 
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polymerase chain reaction (RT-PCR) of ISGs are described in Supplementary 
Materials. 
Flow cytometry 
The descriptions of procedures for T cell surface or intracellular staining and for 
functional assays as well as a list of antibodies or dextramers used for flow 
cytometry are reported in Supplementary Materials (Supplementary Table 4). 
Monocytes, NK cells, B cells, and dead cells were excluded by staining with anti-
CD14, -CD16, -CD19, -CD56 monoclonal antibodies (mAbs) and Fixable Viability 
Dye eFluor® 780 (dump channel). 
Statistics 
The collected data underwent statistical analysis with GraphPad Prism® 6 software 
(GraphPad Software). Comparisons between healthy donors (HDs) and patients 
and between patients with different responses to therapy were analyzed with the 
Mann-Whitney test. Comparisons between patients at different time points were 
analyzed with the Wilcoxon matched-pairs signed-rank test. Correlations between 
tests and clinical data were analyzed with linear regression analysis or the 
Spearman rank coefficient test. In all tests, p <0.05 was considered statistically 
significant. 
 
Results  
HCV- and AE-specific CD8+ T cells parallel in patients with cHCV infection  
The capacity to form IFN--spots (as detected by ELISPOT assay) in response to 
both HCV epitope and AE pools by CD8+ T cells was significantly higher and wider 
in cHCV patients than in HDs (Supplementary Fig. 1A,B). However, despite the 
multispecificity of these IFN--producing CD8+ T cells in cHCV patients, they 
appeared at very low frequencies. No correlation was found between the ELISPOT-
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IFN- responses to HCV epitopes or AEs and various clinical markers of hepatitis 
activity tested (alanine aminotransferase [ALT], viral load, and histological activity 
index [HAI] score). Thus, we enumerated directly ex vivo the entire HCV- or AE-
specific CD8+ T cell populations, irrespective of their function or differentiation 
phase, by using both dextramers of HLA-A*0201 molecules complexed to MYH9478-
486, MYH9741-749, VIME78-87, VIME225-233, or ACTB266-274 peptide, and dextramers of 
HLA-A*0201 molecules complexed to HCV-NS31073-1082, -NS31406-1415, -NS4b1807-
1817, -NS5b2727-2736, or -Core132-140 peptide (Fig. 1A), in combination with anti-CD8 
mAb. Circulating frequencies of these cells were quantified with gating strategy 
indicated allowing to exclude dead cells, monocytes, NK cells and B cells within the 
dump channel including Fixable Viability Dye eFluor780 together with anti-CD14, 
anti-CD16, anti-CD56, and anti-CD19 mAbs conjugated to APCeFluor780 
(Supplementary Fig. 2A). Control dextramers complexed to a non-natural 
irrelevant peptide (ALIAPVHAV) were unable to stain CD8+ T cells, in all samples 
tested (Fig. 1A and Supplementary Fig. 2B): these analyses represented the 
basis on which we set up dextramer+ cell gates of antigen-specific CD8 T cells, 
allowing to exclude cells with unspecific staining. Interestingly, 20 HLA-A2+ cHCV 
patients (including the 14 studied for the ELISPOT assay) (Supplementary Table 
1) presented parallel frequencies of peripheral AE- or HCV-specific (dextramer+) 
CD8+ T cells that were significantly higher than in 13 HDs studied, calculated both 
as a single dextramer percentage (Fig. 1B) and as the sum of dextramer 
percentages by a single patient or HD (Fig. 1C). It is to note the relatively high 
frequency of HCV-specific CD8+ T cells in some HDs (Fig. 1B), likely due to the 
cross-reactivity between NS31073-82 and influenza virus-neuraminidase231-239 
epitopes known to increase both response and frequency of these CD8+ T cells [29, 
30]. In addition, AE-specific (but not HCV-specific [not shown]) CD8+ T cells 
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positively correlated with the “HAI staging” (i.e. the HAI of liver fibrosis) (Fig. 1D), 
but not with ALT or viral load (data not shown). A considerable proportion of both 
HCV-specific and AE-specific CD8+ T cells tested, particularly expressed CD95 and 
(in a lesser degree) the late activation marker HLA-DR, instead of the early 
activation marker CD69, indicating that they are long-term experienced memory T 
cells, as expected in a chronic infection setting (Fig. 2A). Interestingly, dextramer–
CD8+ T cells from cHCV patients expressed an activation phenotype similar to the 
dextramer+CD8+ T cells (Fig. 2A). Activated (HLA-DR+) HCV-specific (but not AE-
specific [not shown]) CD8+ T cells positively correlated with ALT (representing a 
reliable marker of hepatocyte lysis) (Fig. 2B), which suggests that they are involved 
in the lysis of hepatocytes expressing the viral epitopes. In addition, a notable 
proportion of both AE-specific and HCV-specific CD8+ T cells expressed the 
proliferation marker Ki67 (in contrast to the dextramer– cells), suggesting that they 
likely proliferated in response to the relevant antigenic epitopes in vivo (Fig. 2C). In 
support of this possibility, both the HCV- and AE-specific CD8+ T cells tested were 
capable of degranulation (as detected by CD107a upregulation) in response to the 
relevant peptides ex vivo (Fig. 2D), thereby clearly validating their antigen 
specificity.  
Divergent functional capacity of peripheral and intrahepatic AE-specific or HCV-
specific CD8+ T cells  
Both AE-specific and HCV-specific CD8+ T cell populations were mostly 
represented by effector memory (TEM) T cells (CCR7–CD45RA–) and by terminal 
effector memory RA (TEMRA) T cells (CCR7–CD45RA+) containing significantly 
higher percentages of cells co-expressing both the nuclear transcription factors 
Eomesodermin and the transcription factor T-box (Eomes+/T-bet+) than Eomes+/T-
bet– cells (Fig. 3A-C). As a control, CCR7, CD45RA, EOMES, and T-bet gates in 
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the total CD8 population from cHCV patients are reported (Supplementary Fig. 3). 
As expected, Eomes and T-bet were barely represented in the naïve T (TN) or 
central memory T (TCM) cell populations within both AE-specific and HCV-specific 
CD8+ T cells (Fig. 3B). Despite the percentage of PD-1+ cells was nearly similar 
within the total AE-specific and HCV-specific CD8+ T cells (Supplementary Fig. 
4A), the Eomes+/T-bet– subset within both AE-specific and HCV-specific CD8+ T cell 
populations significantly expressed more PD-1 than did the Eomes+/T-bet+ subset, 
providing evidence that Eomes+/T-bet+ cells are mostly PD-1– (Fig. 4A,B) [31, 32]. 
The different HCV genotypes of our patients seem to not influence PD-1 expression 
on the basis of the following observations: a) no significant difference in PD-1 
expression by HCV-specific CD8+ T cells was observed between HCV genotype 1- 
and genotype 2- or 3-infected individuals (Supplementary Fig. 4B); b) PD-1 was 
significantly (or tended to be) less expressed by Eomes+/T-bet+ than by Eomes+/T-
bet– cells in both the patient populations (Supplementary Fig. 4C). However, 
despite the fact that the majority of both AE-specific and HCV-specific CD8+ TEM or 
TEMRA cell populations expressed T-bet, a major transcription factor mediating 
IFN- production [33], they produced very low levels of IFN- (as we had also 
determined with the ELISPOT assay [see Supplementary Fig. 1A,B]) in the 
periphery (Fig. 5A-C). To investigate if IFN--producing cells migrated into the 
inflamed tissue to perform their effector functions, we studied the phenotype and 
function of LILs isolated from the liver biopsies of cHCV patients. Interestingly, both 
CD8+ LIL subsets produced significantly higher levels of TNF-α in response to the 
related peptides ex vivo than the counterparts in the periphery (Fig. 5A-C). Notably, 
AE-specific CD8+ LILs were significantly more efficient than HCV-specific CD8+ LILs 
in performing this function (Supplementary Fig. 5), and produced significantly 
higher levels of IL-2 than the peripheral counterparts (Fig. 5A-C). Interestingly, AE-
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specific CD8+ LILs producing TNF-α frequency parallels, despite in a non-significant 
fashion, the total HAI (grading + staging) score (Fig. 5D). In addition, both AE-
specific (Fig. 6A) and HCV-specific (data not shown) CD8+ TEM cells expressing 
HLA-DR, CD69, or PD-1 accumulated more within the LILs than in the periphery in 
all patients tested (Fig. 6A-C). Similarly, the dextramer–CD8+ T cells with TEM 
phenotype and expressing the various activation markers analyzed were more 
accumulated in the liver than in the periphery (Fig. 6B,C). Antigen-specific CD8+ 
LILs increased their capacity to produce TNF-α and IL-2 upon one round of 
stimulation with autologous irradiated PBMCs in the presence of the relevant 
peptide for 10 days in IL-2-conditioned medium in vitro, confirming that they are 
mainly represented within LIL-derived memory T cells (Supplementary Fig. 6). 
Nevertheless, PD-1 provided inhibitory signals, as evidenced by the improved 
capacity to produce IFN- by both peripheral AE- and HCV-specific CD8+ T cells 
(expressing PD-1) in the presence of a blocking antibody specific to PD-L1 in vitro 
(Supplementary Fig. 7).  
AE-specific CD8+ T cells, CIA, and ISGs 
To provide evidence of the interaction between CIA and IFN-I signaling [7, 8] in 
cHCV infection, we correlated the frequency of AE- or HCV-specific CD8+ T cells 
with the expression of the following ISG transcripts (t) in T cells from both cHCV 
patients and HDs: protein kinase R (PKR) – an IFN-inducible double-stranded RNA 
(dsRNA) activated protein kinase [34]; myxovirus resistance A (MxA) – an IFN-I-
induced protein expressed in various cell types and known for its antiviral activity 
against orthomyxoviruses [35]; and ISG15 – an IFN-I-inducible ubiquitin-like protein 
conjugated with many intracellular substrates via ISGylation [36]. We evaluated the 
baseline and the day (d)30 time point (after 1 month of weekly administration of 
pegylated IFN- ribavirin [pIFN/RIBA]), representing a more chronic IFN-I exposure 
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(and thus chronic IFN-I signaling) and corresponding to 2 days after the fourth 
(weekly) IFN administration. The ISGt levels significantly increased following 
pIFN/RIBA therapy, indicating that T cells are susceptible to the IFN-I signaling in 
vivo (Fig. 7A). Both PKRt and MxAt levels directly correlated with the percentage of 
AE-specific (but not HCV-specific [not shown]) CD8+ T cells in cHCV patients at 
baseline (Fig. 7) and after 1 month of therapy (data not shown), supporting previous 
evidence showing an association between sustained ISG expression (including MxA 
and PKR) and CIA in persistent infections [7, 8, 37]. By contrast, ISG15 inversely 
correlated with AE-specific CD8+ T cell frequency (Fig. 7), consistent with the recent 
evidence showing a strict association of ISG15 deficiency with increased 
immunopathology [38]. 
 
Discussion 
Our findings suggest that AE-specific CD8+ T cells play an important role in 
establishing CIA and disease progression in cHCV infection. The finding that both 
antigen-specific (AE- or HCV-specific) dextramer+CD8+ T cells and dextramer– 
CD8+ T cells expressed an activation phenotype (particularly when they migrate into 
inflamed liver), suggests that a global (polyclonal) T cell activation including both 
activated AE-specific and HCV-specific CD8+ T cells contribute to CIA development 
during cHCV infection. Virus-specific and AE-specific CD8+ T cells may favor the 
recruitment of independent CD8+ T cell populations and likely of inflammatory innate 
immune cells, which contribute to magnify CIA via the production of a storm of 
cytokines (including IFNs and TNFs) ([39, 40]. The evidence showing that activated 
(HLA-DR+) AE-specific (but not HCV-specific) CD8+ T cells correlated with the liver 
fibrosis score suggests that they may be involved in amplifying liver inflammation, 
ultimately driving the progression to fibrosis likely via the production of multiple 
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cytokines including TNF-α [2, 5]. These data are consistent with the results showing 
that the frequency of AE-specific CD8+ LILs producing TNF-α (that was produced by 
AE-specific significantly more than by HCV-specific CD8+ T cells in the liver) 
parallels the HAI score (including “grading” or “inflammatory index” and “staging” or 
“fibrosis index”), supporting thus the possibility that they can contribute to mediate 
immunopathology ultimately leading to fibrosis likely via the activation of hepatic 
stellate cells [41].  
The possibility that AE-specific CD8+ T cells may contribute to CIA development is 
emphasized by the correlation between their frequency and some ISGt levels. The 
direct correlation between AE-specific CD8+ T cell frequency and MxA or PKR is 
consistent with previous experimental data showing that sustained expression of 
ISGs (including MxA and PKR) is associated with CIA development and disease 
progression in persistent infections and that blockade of IFN-I signaling diminishes 
CIA and facilitates clearance of the persistent infection [7, 8, 37, 42]. On the 
contrary, our observation of an inverse correlation between ISG15 and AE-specific 
CD8+ T cell frequency suggests that ISG15 counterbalances MxA and PKR 
functions, ultimately helping to limit chronic inflammation [38]. In support of this 
hypothesis, recent data indicate that inherited ISG15 deficiency in humans 
paradoxically associates with increased IFN-I immunity via the destabilization of 
ubiquitin specific protease 18 (USP18; itself an ISG), which is a negative regulator 
of IFN-I responses [38]. Collectively, our findings support the idea that the balance 
between pro-inflammatory (e.g. MxA and PKR) and anti-inflammatory (e.g. 
ISG15/USP8 axis) ISGs may contribute to establishing a status of low-grade/long-
lasting CIA in cHCV infection. Studies are required to screen additional ISGs [43] for 
possible correlations with the generation of CIA in a larger cohort of cHCV patients.  
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Recently, the division of virus-specific CD8+ T cells into Eomes+/T-bet– and 
Eomes+/T-bet+ cells has been validated to discriminate dysfunctional and functional 
cells, respectively, in various chronic viral infections [22, 44], on the basis of 
previous experimental data showing that T-bet expression in memory T cells is 
associated with the control of chronic infection through down-regulation of PD-1 [31, 
32] and that Eomes is associated with memory and with the control of chronic 
infection when it is co-expressed with T-bet [32]. We found that the majority of both 
AE-specific and HCV-specific CD8+ T cells (in both the periphery and the inflamed 
livers) were confined within TEM and TEMRA cell subsets displaying a 
dysfunctional Th1-like program because they produced very low or undetectable 
amounts of IFN-, despite the notable expression of the related transcription factor 
T-bet. However, both HCV-specific and, to a significantly higher extent, AE-specific 
CD8+ T cells increased their capacity to produce TNF-α and IL-2 in response to the 
relevant antigenic peptides when they migrated into the inflamed liver, despite a 
concomitant increase in PD-1 expression on these cells. The dichotomy between 
the poor IFN- or IL-17 production and the notable TNF-α production by intrahepatic 
CD8+ T cells may be determined by the possibility that these cells have lost the 
polyfunctional capacity that was previously observed in patients resolving acute 
HCV infection [3], likely due to the progressive establishment of the “T cell 
exhaustion” process in chronic infections [28]. In the present study, AE-specific 
CD8+ LILs were more efficient than virus-specific LILs in producing TNF-α. This 
finding is likely because AE-specific CD8+ T cells interact with tissue-resident 
antigen-presenting cells (APCs) that cross-present apoptotic T cells and deliver 
stimulatory (in addition to inhibitory) signals, whereas HCV-specific CD8+ T cells 
target infected hepatocytes that simultaneously express viral antigenic stimuli and 
various inhibitory (but not stimulatory) receptor ligands.  
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Our data differ substantially from those of recent studies showing that the majority 
of virus-specific CD8+ T cells is dysfunctional and associated with low T-bet 
expression in chronic hepatitis B virus (HBV) and HCV infections [22], as well as 
chronic HIV infection [44]. These contradictory findings may reflect the 
heterogeneity of these patients, thus underscoring the need to verify whether a 
genetic background predisposing to viral persistence harbors variants that may 
foster these differences. These discrepancies may also be attributed to the different 
functional assays (e.g. in terms of cytokines produced by T cells) of peripheral and 
tissue-recruited lymphocytes that were performed in the various studies. The finding 
that TNF-α- or IL-2-producing cells were mainly recruited to the liver compartment 
may explain why they were visualized to a lesser extent in the periphery. In addition, 
we cannot exclude that some of the discrepancies could be the consequence of a 
mismatch of the HCV-epitope sequence in the autologous virus as a result of 
mutational escape of the epitope that may profoundly change the virus-specific 
CD8+ T cell phenotype including the PD-1 expression. Further studies are required 
to ascertain the potential impact of such epitope mismatches on these differences.  
Here we propose that both intrahepatic HCV-specific and AE-specific CD8+ T cells 
be defined as semi-functional cells because they can carry out certain functions but 
not others: they have the ability to produce IL-2 and, in particular, TNF-α (a potent 
inflammatory cytokine even contributing to hepatocellular carcinoma promotion [45, 
46], but they do not have polyfunctional capacities, including the production of high 
levels of IFN-γ or IL-17 in response to the relevant epitopes. Our results are 
consistent with reports proposing that intrahepatic virus-specific CD8+ T cells are 
not completely exhausted in cHCV infection [47] and that PD-1+ T cells in chronic 
infections or tumors conserve a crucial level of responses that is instrumental in 
controlling pathogen or tumor spread and in causing minimal tissue damage [48]. 
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Under these conditions, the persistence of functionally competent AE-specific CD8+ 
T cells would strongly promote CIA and immunopathology, particularly via their 
notable production of TNF-α. In this context, it should be taken into account that the 
application of immunotherapy inhibiting PD-1/PD-L1 interaction, despite potentially 
capable to improve anti-viral immune responses [49] [50], may also increase CIA 
when PD-1+ AE-specific CD8 T cells are disengaged from the PD-1-dependent 
control. Nevertheless, this therapy is limited in cHCV infection by the recent 
development of highly effective DAAs providing complete HCV eradication [16]. 
Future studies will be planned to ascertain the possibility that DAAs that elicit 
complete HCV eradication may, as a consequence, reduce/eliminate the immune 
cell activation that is represented by the substrate-inducing AE-specific T cells [2, 
5].  
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Figure legends 
Fig. 1. AE-specific and HCV-specific dextramer+CD8+ T cells parallel in cHCV 
infection. (A) Flow cytometry analyses of dextramer+CD8+ T cells specific to the 
indicated AEs (left) or HCV epitopes (right) in a patient and an HD. The gates of 
dextramer+ antigen-specific CD8 T cells were set up on the basis of the control 
dextramers complexed to a non-natural irrelevant peptide (Dextr neg) that were 
unable to stain CD8+ T cells. (B) Percentage of AE- (left) or HCV-specific (right) 
dextramer+CD8+ T cell populations in 13 HDs and 20 patients (each symbol 
represents a single dextramer+CD8+ T cell percentage, and the grey symbols 
represent dextramer+CD8+ T cell specific to NS31073-82). (C) Sum of percentages of 
AE- (left) or HCV-specific (right) dextramer+CD8+ T cell populations in 13 HDs and 
20 patients (each symbol represents a single patient). Statistical analysis was 
performed with the Mann-Whitney test. ****p <0.00001. (D) Correlation between the 
sum of percentages of the various AE-specific CD8+ T cell populations and HAI 
staging. Statistical analysis was performed with the Spearman correlation. *p <0.01. 
 
Fig. 2. Proliferation and antigen-specific validation of HCV-specific or AE-
specific CD8+ T cells. (A) Mean of percentages of the indicated markers in AE- 
and HCV-specific (dextramer+) CD8+ T cells from 9 cHCV-patients (left graphs), and 
representative flow cytometry analysis in a cHCV-patient (right graph). (B) 
Correlation between the mean of percentages of HLA-DR+ cells in HCV-specific 
CD8+ T cells and ALT levels. Statistical analysis was performed with the Spearman 
correlation; *p <0.01. (C) Mean of percentages of Ki67+ cells in AE- or HCV-specific 
CD8+ T cells, compared with dextramer– (Dxtr–) cells, from 10 cHCV patients (left 
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graph), and representative flow cytometry analysis (right graph). Statistical analysis 
was performed with the Wilcoxon matched-pairs test (the continuous lines link 
Dextramer–CD8+ cells and AE-specific CD8+ T cells; the dotted lines link Dextramer–
CD8+ cells and HCV-specific CD8+ T cells). *p <0.01; **p <0.001. (D) Representative 
flow cytometry analysis of CD107a+ cells in AE- or HCV-specific CD8+ T cells before 
and after stimulation with the relevant peptide from 1 of 4 patients. 
 
Fig. 3. Preponderant expression of Eomes and T-bet in AE-specific and HCV-
specific CD8+ TEM or TEMRA cells. (A) Representative flow cytometry analysis of 
TN, TCM, TEM, or TEMRA cells in AE- or HCV-specific dextramer+CD8+ T cells 
from a patient. (B) Representative flow cytometry analysis of cells expressing T-bet 
and/or Eomes within TN, TCM, TEM, or TEMRA cells present in AE-CD8+ T cells or 
HCV-CD8+ T cells from a cHCV patient. (C) Mean of percentages of T-bet–/Eomes+ 
and T-bet+/Eomes+ cells within TEM or TEMRA cells present in AE-specific (top 
graph) or HCV-specific (bottom graph) CD8+ T cells from 10 patients. Statistical 
analysis was performed with the Wilcoxon matched-pairs test. *p <0.01. 
 
Fig. 4. Prevalent expression of PD-1 in Eomes+/T-bet– subset of AE-specific or 
HCV-specific CD8+ T cells. (A) Representative flow cytometry analysis of PD-1+ 
cells within the Eomes+/T-bet– or Eomes+/T-bet+ cells present in AE- or HCV- 
specific CD8+ T cells from a patient. (B) Mean of percentages of PD-1+ cells within 
the Eomes+/T-bet– or Eomes+/T-bet+ cells present in AE-specific (empty bars) or 
HCV-specific (filled bars) dextramer+CD8+ T cells from 10 patients. Statistical 
analysis was performed with the Wilcoxon matched-pairs test. *p <0.01; **p <0.001.   
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Fig. 5. Differential functions of peripheral and liver-infiltrating AE-specific or 
HCV-specific CD8+ T cells. Flow cytometry analyses of the indicated cytokines by 
AE-specific (A) or HCV-specific (B) CD8+ T cells, stained with the pool of the related 
dextramers, in PBMCs or LILs of a patient, stimulated (or not) with the pool of the 
relevant peptides. Dot plot analyses are gated on CD8+dextramer+ cells and show 
percentages of cytokine-producing cells. (C) Percentage of cells producing the 
indicated cytokines in AE-specific (left graph) or HCV-specific (right graph) CD8+ T 
cells in response to the related peptides from PBMCs or LILs of 13 and 5 patients, 
respectively. Data are represented with background (no stimulation) subtracted. 
Statistical analysis was performed with the Wilcoxon matched-pairs test. **p <0.001; 
***p <0.0001; ****p <0.00001. (D) Relationship between HAI and percentage of AE-
specific CD8+ T cells producing TNF-α.  
 
Fig. 6. Compartmentalization of activated dextramer+AE-specific or 
dextramer–CD8+ T cells with effector phenotype in inflamed liver. (A) 
Percentage of AE-specific CD8+ T cells in PBMCs or LILs from the 5 patients 
providing sufficient amounts of LILs to perform both functional (see Fig. 5) and 
phenotype assays (left graph), and representative flow cytometry analysis (right 
graph). Statistical analysis was performed with the Wilcoxon matched-pairs test. *p 
<0.01. (B) Percentages of TN, TCM, TEM, TEMRA cells in AE-specific dextramer+ 
or dextramer–CD8+ T cells from PBMCs or LILs of 4 patients tested (left graph), and 
representative flow cytometry analysis (right graph). Statistical analysis was 
performed with the Wilcoxon matched-pairs test. *p <0.01. (C) Percentages of HLA-
DR+, CD69+, PD-1+, CD95+ cells in AE-specific or dextramer–CD8+ T cells from 
PBMCs or LILs of 4 patients analyzed (left graph), and representative flow 
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cytometry analysis (right graph). Statistical analysis was performed with the 
Wilcoxon matched-pairs test. *p <0.01.  
 
Fig. 7. Correlation between AE-specific CD8+ T cells and ISGs. (A) Levels of 
PKR (left graph), MxA (central graph), and ISG15 (right graph) in T cells of patients 
at baseline (time [T]0) and after 1 month (T1) of IFN-based therapy. Statistical 
analysis was performed with the Wilcoxon matched-pairs test. *p <0.01. (B) 
Correlations between the sum of percentages of AE-specific (dextramer+) CD8+ T 
cells and PKR (left graph), MxA (central graph), or ISG15 (right graph) levels in T 
cells at baseline. Statistical analyses in all panels were performed with the 
Spearman correlation. *p <0.01.  
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